A case report of concurrent occurrence of two inherited axonopathies within a family: the benefit of whole-exome sequencing

References

• Sadr Z, Ghasemi A, Rohani M, et al. NMNAT1 and hereditary spastic paraplegia (HSP): expanding the phenotypic spectrum of NMNAT1 variants. Neuromuscul Disord. 2023;33(4):295–301. doi: 10.1016/j.nmd.2023.02.001.
   PubMed Web of Science ®Google Scholar
• Srivastava S, D’Amore A, Cohen JS, et al. Expansion of the genetic landscape of ERLIN2-related disorders. Ann Clin Transl Neurol. 2020;7(4):573–578. doi: 10.1002/acn3.51007.
   PubMed Web of Science ®Google Scholar
• Chen S, Zou JL, He S, et al. More autosomal dominant SPG18 cases than recessive? The first AD-SPG18 pedigree in chinese and literature review. Brain Behav. 2021;11(12):e32395.
   PubMed Web of Science ®Google Scholar
• Boutry M, Morais S, Stevanin G. Update on the genetics of spastic paraplegias. Curr Neurol Neurosci Rep. 2019;19(4):18. doi: 10.1007/s11910-019-0930-2.
   PubMed Web of Science ®Google Scholar
• Laurá M, Pipis M, Rossor AM, et al. Charcot-Marie-tooth disease and related disorders: an evolving landscape. Curr Opin Neurol. 2019;32(5):641–650. doi: 10.1097/WCO.0000000000000735.
   PubMed Web of Science ®Google Scholar
• Chandhok G, Lazarou M, Neumann B. Structure, function, and regulation of mitofusin-2 in health and disease. Biol Rev Camb Philos Soc. 2018;93(2):933–949. doi: 10.1111/brv.12378.
   PubMed Web of Science ®Google Scholar
• Abati E, Manini A, Velardo D, et al. Clinical and genetic features of a cohort of patients with MFN2-related ­neuropathy. Sci Rep. 2022;12(1):6181. doi: 10.1038/s41598-022-10220-0.
   PubMed Web of Science ®Google Scholar
• Fridman V, Murphy SM. The spectrum of axonopathies: from CMT2 to HSP. Neurology. 2014;83(7):580–581. doi: 10.1212/WNL.0000000000000700.
   PubMed Web of Science ®Google Scholar
• Bis-Brewer DM, Danzi MC, Wuchty S, et al. A network biology approach to unraveling inherited axonopathies. Sci Rep. 2019;9(1):1692. doi: 10.1038/s41598-018-37119-z.
   PubMed Web of Science ®Google Scholar
• Elert-Dobkowska E, Stepniak I, Krysa W, et al. Next-generation sequencing study reveals the broader variant spectrum of hereditary spastic paraplegia and related phenotypes. Neurogenetics. 2019;20(1):27–38. doi: 10.1007/s10048-019-00565-6.
   PubMed Web of Science ®Google Scholar
• Lin S, Xu LQ, Xu GR, et al. Whole exome sequencing reveals a broader variant spectrum of Charcot-Marie-tooth disease type 2. Neurogenetics. 2020;21(2):79–86. doi: 10.1007/s10048-019-00591-4.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhao Z, Shen H, et al. Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations. BMC Neurol. 2022;22(1):180. doi: 10.1186/s12883-022-02708-z.
   PubMed Web of Science ®Google Scholar
• Pashaei M, Davarzani A, Hajati R, et al. Description of clinical features and genetic analysis of one ultra-rare (SPG64) and two common forms (SPG5A and SPG15) of hereditary spastic paraplegia families. J Neurogenet. 2021;35(2):84–94. doi: 10.1080/01677063.2021.1895146.
   PubMed Web of Science ®Google Scholar
• Hashemi SS, Hajati R, Davarzani A, et al. Anticipation can be more common in hereditary spastic paraplegia with SPAST mutations than it appears. Can J Neurol Sci. 2022;49(5):651–661. doi: 10.1017/cjn.2021.188.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–424. doi: 10.1038/gim.2015.30.
   PubMed Web of Science ®Google Scholar
• Hu H, Kahrizi K, Musante L, et al. Genetics of intellectual disability in consanguineous families. Mol Psychiatry. 2019;24(7):1027–1039. doi: 10.1038/s41380-017-0012-2.
   PubMed Web of Science ®Google Scholar
• Najmabadi H, Hu H, Garshasbi M, et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature. 2011;478(7367):57–63. doi: 10.1038/nature10423.
   PubMed Web of Science ®Google Scholar
• Namiranian P, Shams M, Gleeson J, et al. ERLIN2 mutations in two Iranian families with hereditary spastic paraplegia. Genetics in the Third Millennium. 2016;14(1):22.
   Google Scholar
• Tian WT, Shen JY, Liu XL, et al. Novel mutations in endoplasmic reticulum lipid raft-associated protein 2 gene cause pure hereditary spastic paraplegia type 18. Chin Med J (Engl). 2016;129(22):2759–2761. doi: 10.4103/0366-6999.193444.
   PubMed Web of Science ®Google Scholar
• Travaglini L, Aiello C, Stregapede F, et al. The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes. Neurogenetics. 2018;19(2):111–121. doi: 10.1007/s10048-018-0545-9.
   PubMed Web of Science ®Google Scholar
• Morais S, Raymond L, Mairey M, et al. Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias. Eur J Hum Genet. 2017;25(11):1217–1228. doi: 10.1038/ejhg.2017.124.
   PubMed Web of Science ®Google Scholar
• Park J-M, Lee B, Kim J-H, et al. An autosomal dominant ERLIN2 mutation leads to a pure HSP phenotype distinct from the autosomal recessive ERLIN2 mutations (SPG18. Sci Rep. 2020;10(1):3295. doi: 10.1038/s41598-020-60374-y.
   PubMed Web of Science ®Google Scholar
• Rydning SL, Dudesek A, Rimmele F, et al. A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia. Eur J Neurol. 2018;25(7):943–e71. doi: 10.1111/ene.13625.
   PubMed Web of Science ®Google Scholar
• Al-Saif A, Bohlega S, Al-Mohanna F. Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. Ann Neurol. 2012;72(4):510–516. doi: 10.1002/ana.23641.
   PubMed Web of Science ®Google Scholar
• Yıldırım Y, Orhan EK, Iseri SA, et al. A frameshift mutation of ERLIN2 in recessive intellectual disability, motor dysfunction and multiple joint contractures. Hum Mol Genet. 2011;20(10):1886–1892. doi: 10.1093/hmg/ddr070.
   PubMed Web of Science ®Google Scholar
• Hikiami R, Yamashita H, Koita N, et al. Charcot-Marie-tooth disease type 2A with an autosomal-recessive inheritance: the first report of an adult-onset disease. J Hum Genet. 2018;63(1):89–92. doi: 10.1038/s10038-017-0353-3.
   PubMed Web of Science ®Google Scholar
• Engelfried K, Vorgerd M, Hagedorn M, et al. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2. BMC Med Genet. 2006;7(1):53. doi: 10.1186/1471-2350-7-53.
   PubMed Web of Science ®Google Scholar
• Cassereau J, Casasnovas C, Gueguen N, et al. Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a patient with CMT. Neurology. 2011;76(17):1524–1526. doi: 10.1212/WNL.0b013e318217e77d.
   PubMed Web of Science ®Google Scholar
• Bansagi B, Griffin H, Whittaker RG, et al. Genetic heterogeneity of motor neuropathies. Neurology. 2017;88(13):1226–1234. doi: 10.1212/WNL.0000000000003772.
   PubMed Web of Science ®Google Scholar
• Antoniadi T, Buxton C, Dennis G, et al. Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability. BMC Med Genet. 2015;16(1):84. doi: 10.1186/s12881-015-0224-8.
   PubMed Web of Science ®Google Scholar
• McCorquodale DS, 3rd, Montenegro G, Peguero A, et al. Mutation screening of mitofusin 2 in Charcot-Marie-tooth disease type 2. J Neurol. 2011;258(7):1234–1239. doi: 10.1007/s00415-011-5910-7.
   PubMed Web of Science ®Google Scholar
• Braathen GJ, Sand JC, Lobato A, et al. MFN2 point mutations occur in 3.4% of Charcot-Marie-tooth families. an investigation of 232 norwegian CMT families. BMC Med Genet. 2010;11(1):48. doi: 10.1186/1471-2350-11-48.
   PubMed Web of Science ®Google Scholar
• Casasnovas C, Banchs I, Cassereau J, et al. Phenotypic spectrum of MFN2 mutations in the Spanish population. J Med Genet. 2010;47(4):249–256. doi: 10.1136/jmg.2009.072488.
   PubMed Web of Science ®Google Scholar
• Taghizadeh S, Vazehan R, Beheshtian M, et al. Molecular diagnosis of hereditary neuropathies by whole exome sequencing and expanding the phenotype spectrum. Arch Iran Med. 2020;23(7):426–433. doi: 10.34172/aim.2020.39.
   PubMed Web of Science ®Google Scholar